Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency's plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency's COVID-19 response efforts.
(this only appears for logged-in users)
| Episode: 23
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
Amy Abernethy, Principal Deputy Commissioner and Acting CIO, FDA